Thank you, Madam Chair.
Thank you to the witnesses for the testimony today.
It's nice to have Neurological Health Charities before us. I was on the committee, along with Ms. Smith, when we had the subcommittee on neurological disorders. I know that Shannon from your office was very helpful on some of the input that your organization put forward. It's great to have your input on this study on technological innovation.
I want to get your perspectives on how Canada is doing when it comes to international collaboration. I know we have a lot of hope for some of the work that's being done abroad with Germany and France and the U.K. on having that broader population study.
Are we doing enough of that type of collaboration that enables research and innovation?